Literature DB >> 1323740

Transcription of bovine leukemia virus in peripheral blood cells obtained during early infection in vivo.

K Radke1, T J Sigala, D Grossman.   

Abstract

Bovine leukemia virus (BLV) is transcriptionally silent in most circulating peripheral blood mononuclear cells (PBMCs) of animals with well-established infections. Using PBMCs from a newly infected sheep, we asked whether viral transcription proceeded differently during the initial months of infection, when the prevalence of BLV-infected cells and the host's immunological response change markedly. Shortly after being injected with BLV, the animal displayed a characteristic, transient increase in PBMCs that transcribed BLV when cultured. Even when transcriptionally competent PBMCs were most prevalent (1.2%), only rare cells in the circulation (1 in 50,000) contained enough BLV transcripts to be identified readily by in situ hybridization. However, at one point several weeks later, some PBMCs appeared to contain small amounts of BLV RNA as soon as they had been purified from blood. Throughout this period, BLV-transcribing PBMCs greatly outnumbered virus-producing cells, which were counted using a new infectious centers assay. Its viscous medium reduced cell to cell contact among PBMCs, enabling increased detection of BLV-producing cells at a time when virus-specific killer cells might be active. Early infection was polyclonal, and most infected PBMCs transcribed BLV upon being cultured. By 2 months after infection, provirus-containing cells were as abundant as they had been earlier, but few cells transcribed BLV. These results suggest that BLV-infected cells are more easily stimulated to transcribe the provirus and produce infectious virus during the early months of a new infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323740     DOI: 10.1016/0882-4010(92)90095-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  16 in total

1.  Bovine leukemia virus pre-miRNA genes' polymorphism.

Authors:  I M Zyrianova; S N Koval'chuk
Journal:  RNA Biol       Date:  2018       Impact factor: 4.652

2.  Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.

Authors:  C Merezak; C Pierreux; E Adam; F Lemaigre; G G Rousseau; C Calomme; C Van Lint; D Christophe; P Kerkhofs; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Dissemination of bovine leukemia virus-infected cells from a newly infected sheep lymph node.

Authors:  B E Fulton; M Portella; K Radke
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions.

Authors:  E R Johnston; K Radke
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Peripheral blood mononuclear cells from sheep infected with a variant of bovine leukemia virus synthesize envelope glycoproteins but fail to induce syncytia in culture.

Authors:  E R Johnston; M A Powers; L C Kidd; K Radke
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex.

Authors:  K Boris-Lawrie; V Altanerova; C Altaner; L Kucerova; H M Temin
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.

Authors:  Michal Reichert
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-24

8.  Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.

Authors:  Elizabeth R Johnston; Lorraine M Albritton; Kathryn Radke
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  A detailed molecular analysis of complete bovine leukemia virus genomes isolated from B-cell lymphosarcomas.

Authors:  Gonzalo Moratorio; Sabrina Fischer; Sergio Bianchi; Lorena Tomé; Gonzalo Rama; Gonzalo Obal; Federico Carrión; Otto Pritsch; Juan Cristina
Journal:  Vet Res       Date:  2013-03-18       Impact factor: 3.683

Review 10.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.